References
- HsiuSLTsaoCWTasiYCDeterminations of morin, quercetin and their conjugate metabolites in serumBiol Pharm Bull200124896796911510497
- FangSHHouYCChangWCMorin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shockLife Sci200374674375614654167
- SivaramakrishnanVShilpaPNPraveen KumarVRAttenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-MorinChem Biol Interact20081711798817950263
- ZhangRKangKAPiaoMJCellular protection of morin against the oxidative stress induced by hydrogen peroxideChem Biol Interact20091771212718793623
- KangDGMoonMKSohnEJEffects of morin on blood pressure and metabolic changes in fructose-induced hypertensive ratsBiol Pharm Bull200427111779178315516722
- PariharVKPrabhakarKRVeerapurVPAnticlastogenic activity of morin against whole body gamma irradiation in Swiss albino miceEur J Pharmacol20075571586517207789
- YuZFongWPChengCHThe dual actions of morin (3,5,7,2′,4′-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activityJ Pharmacol Exp Ther2006316116917516169936
- ChoYMOnoderaHUedaMA 13-week subchronic toxicity study of dietary administered morin in F344 ratsFood Chem Toxicol200644689189716442199
- HouYCChaoPDHoHJProfound difference in pharmacokinetics between morin and its isomer quercetin in ratsJ Pharm Pharmacol200355219920312631412
- KoKTNeedhamTEZiaHEmulsion formulations of testosterone for nasal administrationJ Microencapsul19981521972059532525
- KrishnaiahYSRPharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugsJ Bioequiv Availab2010222836
- KangBKLeeJSChonSKDevelopment of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogsInt J Pharm20042741–2657315072783
- ElnaggarYSEl-MassikMAAbdallahOYSelf-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimizationInt J Pharm20093801–213314119635537
- BalakrishnanPLeeBJOhDHEnhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS)Eur J Pharm Biopharm200972353954519298857
- ZhangPLiuYFengNPPreparation and evaluation of self-microemulsifying drug delivery system of oridoninInt J Pharm20083551–226927618242895
- SetthacheewakulSMahattanadulSPhadoongsombutNDevelopment and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in ratsEur J Pharm Biopharm201076347548520659556
- DateAADesaiNDixitRSelf-nanoemulsifying drug delivery systems: formulation insights, applications and advancesNanomedicine (Lond)20105101595161621143036
- GursoyRNBenitaSSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsBiomed Pharmacother200458317318215082340
- MaitiKMukherjeeKGantaitACurcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in ratsInt J Pharm20073301–215516317112692
- CuiFShiKZhangLBiodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluationJ Control Release2006114224225016859800
- YanyuXYunmeiSZhipengCThe preparation of silybin– phospholipid complex and the study on its pharmacokinetics in ratsInt J Pharm20063071778216300915
- CraigDQMBarkerSABanningDAn investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopyInt J Pharm19951141103110
- DateAANagarsenkerMSDesign and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetilInt J Pharm20073291–216617217010543
- PorterCJHPoutonCWCuineJFCharmanWNEnhancing intestinal drug solubilisation using lipid-based delivery systemsAdv Drug Deliv Rev200860667369118155801
- TianXJYangXWYangXStudies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer modelInt J Pharm20093671–2586418848870
- MacGregorKJEmbletonJKLacyJEInfluence of lipolysis on drug absorption from the gastro-intestinal tractAdv Drug Deliv Rev19972513346
- AungstBJIntestinal permeation enhancersJ Pharm Sci200089442944210737905
- HaussDJOral lipid-based formulationsAdv Drug Deliv Rev200759766767617618704
- BugginsTRDickinsonPATaylorGThe effects of pharmaceutical excipients on drug dispositionAdv Drug Deliv Rev200759151482150318198495
- ConstantinidesPPWasanKMLipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studiesJ Pharm Sci200796223524817051593